+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 209 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5693560
The Medical Devices sector report, “Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Inhalers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inhaler devices deliver medication to the lungs.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Inhalers Overview
3 Products under Development
3.1 Inhalers - Pipeline Products by Stage of Development
3.2 Inhalers - Pipeline Products by Segment
3.3 Inhalers - Pipeline Products by Territory
3.4 Inhalers - Pipeline Products by Regulatory Path
3.5 Inhalers - Pipeline Products by Estimated Approval Date
3.6 Inhalers - Ongoing Clinical Trials
4 Inhalers - Pipeline Products under Development by Companies
4.1 Inhalers Companies - Pipeline Products by Stage of Development
4.2 Inhalers - Pipeline Products by Stage of Development
5 Inhalers Companies and Product Overview6 Inhalers- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Inhalers - Pipeline Products by Stage of Development
  • Inhalers - Pipeline Products by Segment
  • Inhalers - Pipeline Products by Territory
  • Inhalers - Pipeline Products by Regulatory Path
  • Inhalers - Pipeline Products by Estimated Approval Date
  • Inhalers - Ongoing Clinical Trials
  • Inhalers Companies - Pipeline Products by Stage of Development
  • Inhalers - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Inhalers - Pipeline Products by Stage of Development
  • Inhalers - Pipeline Products by Segment
  • Inhalers - Pipeline Products by Territory
  • Inhalers - Pipeline Products by Regulatory Path
  • Inhalers - Pipeline Products by Estimated Approval Date
  • Inhalers - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1nhaler Ltd
  • Acorda Therapeutics Inc
  • Advent Pharmaceuticals Pty Ltd
  • Aerami Therapeutics Inc
  • Aespira Ltd.
  • AKELA Pharma Inc. (Inactive)
  • AsMedic Ltd.
  • Bayer AG
  • Bellerophon Therapeutics Inc
  • Cambridge Healthcare Innovations Ltd
  • Cipla Ltd
  • Covinhaler LLP
  • Creare LLC
  • De Motu Cordis Pty Ltd
  • DMK Pharmaceuticals Corp
  • Drexel University
  • Eli Lilly and Co
  • Engage Therapeutics Inc
  • Findair Sp zoo
  • FocusStart LLC
  • Glenmark Pharmaceuticals Ltd
  • GSK plc
  • Hovione Technology Ltd
  • Iconovo AB
  • Lupin Pharmaceuticals Inc
  • MannKind Corp
  • Medihale Ltd (Inactive)
  • Monash University
  • Nektar Therapeutics
  • North Carolina State University
  • Novartis AG
  • Ology Bioservices Inc
  • OPKO Health Inc
  • OtiTopic Inc
  • Pai Life Sciences Inc
  • Phargentis SA
  • Pharmaxis Ltd
  • Pneuma Respiratory Inc
  • Pure Scientific Technologies Inc
  • PureIMS BV
  • Quench Medical Inc
  • Resolve Digital Health Inc
  • Respira Therapeutics Inc
  • Respirent Pharmaceuticals Co Ltd
  • Rhinomed Ltd
  • Sandoz International GmbH
  • Seng Vital International GmbH
  • Sheffield Hallam University
  • Shin Nippon Biomedical Laboratories Ltd
  • Sinsin Pharmaceutical Co Ltd
  • Softhale NV
  • Spyryx Biosciences Inc (Inactive)
  • Teva Pharmaceutical Industries Ltd
  • Transpire Bio Inc
  • University of Kansas
  • University of Sydney
  • University of Texas Medical Branch at Galveston
  • Uscom Ltd
  • Vectura Group Plc
  • Veoli Ltd
  • Verona Pharma Plc
  • Virginia Commonwealth University